BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 26239840)

  • 1. Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast.
    Norkiene M; Stonyte J; Ziogiene D; Mazeike E; Sasnauskas K; Gedvilaite A
    BMC Biotechnol; 2015 Aug; 15():68. PubMed ID: 26239840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence rates of HPyV6, HPyV7, TSPyV, HPyV9, MWPyV and KIPyV polyomaviruses among the healthy blood donors.
    Šroller V; Hamšíková E; Ludvíková V; Musil J; Němečková Š; Saláková M
    J Med Virol; 2016 Jul; 88(7):1254-61. PubMed ID: 26630080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and late promoters of BK polyomavirus, Merkel cell polyomavirus, Trichodysplasia spinulosa-associated polyomavirus and human polyomavirus 12 are among the strongest of all known human polyomaviruses in 10 different cell lines.
    Moens U; Van Ghelue M; Ludvigsen M; Korup-Schulz S; Ehlers B
    J Gen Virol; 2015 Aug; 96(8):2293-2303. PubMed ID: 25968129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History of Cutaneous Human Polyomavirus Infection in Healthy Individuals.
    Bopp L; Wieland U; Hellmich M; Kreuter A; Pfister H; Silling S
    Front Microbiol; 2021; 12():740947. PubMed ID: 34733257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New, newer, newest human polyomaviruses: how far?].
    Us D
    Mikrobiyol Bul; 2013 Apr; 47(2):362-81. PubMed ID: 23621738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human polyomaviruses in disease and cancer.
    Dalianis T; Hirsch HH
    Virology; 2013 Mar; 437(2):63-72. PubMed ID: 23357733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of recombinant trichodysplasia spinulosa-associated polyomavirus VP1-derived virus-like particles using chromatographic techniques.
    Zaveckas M; Goda K; Ziogiene D; Gedvilaite A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1090():7-13. PubMed ID: 29778875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
    Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
    Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Diversity of the Noncoding Control Region of the Novel Human Polyomaviruses.
    Moens U; Prezioso C; Pietropaolo V
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33297530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin.
    van der Meijden E; Bialasiewicz S; Rockett RJ; Tozer SJ; Sloots TP; Feltkamp MC
    PLoS One; 2013; 8(11):e81078. PubMed ID: 24278381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis and Evolution of Glycan Receptor Specificities within the Polyomavirus Family.
    Ströh LJ; Rustmeier NH; Blaum BS; Botsch J; Rößler P; Wedekink F; Lipkin WI; Mishra N; Stehle T
    mBio; 2020 Jul; 11(4):. PubMed ID: 32723915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Evaluation of a Broad Bead-Based Multiplex Immunoassay To Measure IgG Seroreactivity against Human Polyomaviruses.
    Kamminga S; van der Meijden E; Wunderink HF; Touzé A; Zaaijer HL; Feltkamp MCW
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex detection in tonsillar tissue of all known human polyomaviruses.
    Sadeghi M; Wang Y; Ramqvist T; Aaltonen LM; Pyöriä L; Toppinen M; Söderlund-Venermo M; Hedman K
    BMC Infect Dis; 2017 Jun; 17(1):409. PubMed ID: 28595595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma.
    Herberhold S; Hellmich M; Panning M; Bartok E; Silling S; Akgül B; Wieland U
    Med Microbiol Immunol; 2017 Apr; 206(2):93-103. PubMed ID: 27832373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA from Human Polyomaviruses, MWPyV, HPyV6, HPyV7, HPyV9 and HPyV12 in Cutaneous T-cell Lymphomas.
    Bergallo M; Daprà V; Fava P; Ponti R; Calvi C; Montanari P; Novelli M; Quaglino P; Galliano I; Fierro MT
    Anticancer Res; 2018 Jul; 38(7):4111-4114. PubMed ID: 29970537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyomaviruses of the skin: integrating molecular and clinical advances in an emerging class of viruses.
    Sheu JC; Tran J; Rady PL; Dao H; Tyring SK; Nguyen HP
    Br J Dermatol; 2019 Jun; 180(6):1302-1311. PubMed ID: 30585627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae.
    Sasnauskas K; Bulavaite A; Hale A; Jin L; Knowles WA; Gedvilaite A; Dargeviciūte A; Bartkeviciūte D; Zvirbliene A; Staniulis J; Brown DW; Ulrich R
    Intervirology; 2002; 45(4-6):308-17. PubMed ID: 12602348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure analysis of the major capsid proteins of human polyomaviruses 6 and 7 reveals an obstructed sialic acid binding site.
    Ströh LJ; Neu U; Blaum BS; Buch MH; Garcea RL; Stehle T
    J Virol; 2014 Sep; 88(18):10831-9. PubMed ID: 25008942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for polyomaviruses: opportunities and challenges.
    Dalianis T
    Immunotherapy; 2012 Jun; 4(6):617-28. PubMed ID: 22788129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
    Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
    Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.